New immunotherapy for multiple myeloma proves

<ul>
<li style="text-align:justify"><strong>Researchers at the Spanish National Cancer Research Center (CNIO) and the 12 de Octubre University Hospital have developed a new cell-based immunotherapy to treat multiple myeloma </strong><br />
&nbsp;</li>
<li><strong>The new immunotherapy is based on <em>STAb cells</em> and has yet to pass clinical trials. </strong><br />
&nbsp;</li>
<li><strong>The study is published in <em>Science Translational Medicine</em>, with head of the H12O-CNIO Cancer Immunotherapy Clinical Research Unit Luis &Aacute;lvarez-Vallina as senior author.</strong></li>
</ul>

Related Keywords

Spain , Barcelona , Comunidad Autonoma De Cataluna , Madrid , Salamanca , Castillay Leóp , Spanish , Onechain Immunotherapeutics , Josep Carreras Leukemia Research Institute , Complutense University Of Madrid , University Of Salamanca , Method Of Research , Cancer Immunotherapy Clinical Research Unit Luis , Rocket Pharmaceuticals Inc , Spanish National Cancer Research Center , Octubre University Hospital , Science Translational Medicine , Complutense University , Instituto De Investigaci , Sanitaria Hospital , Josep Carreras Leukemia Research , Rocket Pharmaceuticals ,